A double-blind, randomized, multicenter, phase II study of the safety and efficacy of two rituximab regimens in subjects with moderate to severe active rheumatoid arthritis receiving stable doses of methotrexate.

Trial Profile

A double-blind, randomized, multicenter, phase II study of the safety and efficacy of two rituximab regimens in subjects with moderate to severe active rheumatoid arthritis receiving stable doses of methotrexate.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2014

At a glance

  • Drugs Methotrexate; Rituximab
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Genentech
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Oct 2011 Actual initiation date changed from Apr 2006 to Aug 2005 as reported by ClinicalTrials.gov.
    • 06 Oct 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top